VRSN Form 4: D. James Bidzos Disposes 9,000 Shares; 10b5-1 Plan Noted
Rhea-AI Filing Summary
VeriSign insider sales by CEO D. James Bidzos: Between September 9-11, 2025 the reporting person sold a total of 9,000 shares of VeriSign common stock in multiple transactions at prices ranging approximately from $280.51 to $289.55. The transactions were reported as made pursuant to a written Rule 10b5-1 plan (box checked). The filing notes inclusion of 134.7365 dividend-equivalent restricted stock units acquired August 27, 2025, in respect of previously granted restricted stock units. Following these reported sales, the reporting person’s beneficial ownership is shown as 485,438.7009 shares. The form is a standard Section 16 disclosure of insider sales with weighted-average prices and ranges disclosed for multi-price trades.
Positive
- Transactions were made pursuant to a written Rule 10b5-1 plan, indicating pre-scheduled, documented sales.
- Filing discloses dividend-equivalent RSUs (134.7365 shares) acquired Aug 27, 2025, showing the form includes compensatory adjustments.
Negative
- None.
Insights
TL;DR: CEO executed planned, disclosed sales totaling 9,000 shares over three days; ownership remains substantial.
The sales total 9,000 shares executed across 9/9–9/11/2025 at per-share prices reported in specified weighted-average ranges from about $280.51 to $289.55. The report explicitly indicates the transactions were made under a written Rule 10b5-1 plan, which typically schedules sales regardless of short-term company developments. Post-transactions beneficial ownership is 485,438.7009 shares, reflecting a modest reduction relative to prior holdings; the filing also records 134.7365 dividend-equivalent RSUs acquired Aug 27, 2025. From a financial-materiality perspective, these appear routine and fully disclosed rather than an unexpected corporate event.
TL;DR: Proper Section 16 disclosure and 10b5-1 plan checkbox indicate procedural compliance with insider trading rules.
The Form 4 is executed and signed by power of attorney, lists the reporting person’s roles (Exec. Chairman, President & CEO), and checks the box indicating sales pursuant to a 10b5-1 written plan. The filing provides weighted-average prices and ranges for multi-price trades and documents recent dividend-equivalent RSU acquisition. Governance-wise, the form demonstrates transparent reporting and adherence to required insider-trading disclosure formats; no indications of corrective amendments or missing mandatory details are present in the submitted text.